title

Natural gas prices are skyrocketing as Middle East conflict halts key LNG production and threatens the Strait of Hormuz. Europe and Asia face potential economic pain reminiscent of 2022—but how long can this last before it reshapes global energy?

Biogen faces declining royalties from a major multiple sclerosis drug in the coming years, yet one Wall Street firm sees significant room for the stock to run. New therapies in eye care and immunology could more than offset the loss—what does this mean for long-term investors?

Ripple is putting the XRP Ledger's new lending features through extraordinary mathematical scrutiny before letting them go live. But will formal verification catch every possible flaw in this Layer-1 experiment? The stakes are higher than most realize...